Spyglass PharmaSGP

13F holders, Q1 2026 (March 31)
35holders
1famous investor
$25.85avg. 13F price*

At the end of Q1 2026, 35 institutions reported holding Spyglass Pharma Inc. (SGP) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($207.8M), NEA Management Company, LLC ($191.5M) and Sands Capital Alternatives, LLC ($64.8M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).

Company
Spyglass Pharma Inc.
CUSIP
85220G109
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2026: 35Q1 2026Q2 2026: 52Q2 2026

Total Exit/New Position Q1 2026

InstitutionsTotal Value
New Positions31$642.4M
Exits0$0

Ownership 35 holders

Ra Capital Management, L.P. 2.20% New 8,021,117 $207.8M
NEA Management Company, LLC 10.89% New 7,392,301 $191.5M
Sands Capital Alternatives, LLC 15.38% New 2,500,012 $64.8M
Samsara Biocapital, LLC 5.31% New 2,109,953 $54.7M
T. Rowe Price Associates Inc. 0.00% New 704,440 $18.3M
Vestal Point Capital, LP 0.48% New 666,760 $17.3M
Deerfield Management Company, L.P. 0.20% New 550,000 $14.3M
JPMorgan Chase & Co. 0.00% New 577,109 $13.5M
Millennium Management 0.01% New 468,794 $12.1M
Vanguard Capital Management LLC 0.00% — 434,813 $11.3M
First Light Asset Management, LLC 0.87% New 375,000 $9.7M
Franklin Resources Inc. 0.00% New 300,000 $7.8M
Affinity Asset Advisors, LLC 0.39% New 250,000 $6.5M
Aberdeen Group plc 0.01% New 220,454 $5.7M
BlackRock, Inc. 0.00% New 144,739 $3.8M
Geode Capital Management, LLC 0.00% New 126,540 $3.3M
Monashee Investment Management LLC 1.59% New 95,000 $2.5M
Vanguard Fiduciary Trust Co. 0.00% — 59,782 $1.5M
Charles Schwab Investment Management Inc. 0.00% New 59,610 $1.5M
Alyeska Investment Group, L.P. 0.00% New 57,000 $1.5M
TD Asset Management Inc 0.00% New 47,580 $1.2M
Ameriprise Financial Inc. 0.00% New 44,477 $1.2M
Marshall Wace, LLP 0.00% New 29,348 $760K
Bank of America Corp. 0.00% New 28,020 $726K
Northern Trust Corp. 0.00% New 20,862 $541K
Goldman Sachs Group Inc. 0.00% New 19,283 $500K
State Street Corp. 0.00% New 17,250 $447K
Manufacturers Life Insurance Company, The 0.00% New 11,870 $308K
Squarepoint Ops LLC 0.00% New 7,811 $202K
Vanguard Global Advisers, LLC 0.00% — 4,927 $128K
Morgan Stanley 0.00% New 4,179 $108K
Vanguard Portfolio Management LLC 0.00% — 3,680 $95K
UBS Group AG 0.00% New 455 $12K
Barclays PLC 0.00% New 140 $4K
Royal Bank of Canada 0.00% New 85 $2K

"% of holder's portfolio" is SGP's weight in each manager's 13F, not the share of Spyglass Pharma Inc. the manager owns.